Homepage | Forward to a Friend | Make a Donation |
|
eLetter #682 | October 28, 2016 |
|
Low Income Home Energy Assistance Program
The U.S. Department of Health and Human Services (HHS) offers an energy assistance program to families who qualify. The Low Income Home Energy Assistance Program, or LIHEAP, helps keep families safe during the brutal winter months by offering federally-funded assistance to help with:
- Home energy bills
- Energy crises
- Weatherization and energy-related minor home repairs
Learn more about this opportunity >>
|
Study Funded to Help Manage Fatigue and Sleep in People Living with Chronic Illness
The College of Nursing at the University of Massachusetts-Amherst has been awarded a five-year $1.23 million grant from the National Institute of Nursing Research to investigate new technologies to help individuals living with chronic illness manage fatigue and impaired sleep.
The university's UManage Center to Build the Science of Symptom
Self-Management will help individuals with chronic illness live healthier, more functional lives, said Cynthia Jacelon, professor of
nursing and center director. "Nurse-led interdisciplinary teams will
use emerging technologies being developed on the UMass Amherst campus
to help manage symptoms affecting millions of individuals with chronic
conditions that interfere with living life to the fullest."
Read more about this study >>
|
Video: Turning a Moment into a Movement
In the 2016 Opening Keynote from the Scleroderma Foundation's National Patient Education Conference in New Orleans, Mary Woolley, President and CEO, Research!
America, discusses the current state of federal health research agency
budgets, shares relevant public opinion survey data and provides
insights on how to effectively communicate with the candidates, public,
policymakers and the media.
Watch the entire session >>
|
|
|
|
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
|
|
|